Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MED14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TRIM24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGAT4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DBT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPHLN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSTM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCOA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMGT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSX2IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR180 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASRGL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGSF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMOD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on